Edesa Biotech (NASDAQ:EDSA) Stock, Quote.Headers.trade-ideas

Edesa Biotech

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

movers image

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ALAR

ATSG

CSWC

EDSA

EFSH

NLSP

NSSC

NUWE

OKLO

OMIC

SIFY

STAF

TGTX

VSTE

YUMC

Why Yum China Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

Penny Stocks

Small Cap

AAMC

ATNF

BURU

CCCC

CISO

INAB

IOAC

MyMD Pharmaceuticals, Inc. - Common Stock

MYMD

MYNA

NXTP

PTPI

RSLS

SFWL

VSME

WLGS

ZJYL

Shares of  ReShape Lifesciences Inc. (NASDAQ: RSLS) rose sharply in pre-market trading after the company said it received FDA PMA supplement approval for its next-generation Lap-Band 2.0 FLEX.

ReShape Lifesciences shares jumped 44.6% to $0.3630 in pre-market trading.

Why ReShape Lifesciences Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket

Intraday Update

ADSK

AGIL

ANGH

ATGL

Alterity Therapeutics Limited - American Depositary Shares

ATHE

ATPC

CNTB

GHRS

GNTA

GSX Techedu Inc. American Depositary Shares

GOTU

GYRE

HSCS

MIRA

PXMD

RVYL

SHOT

SPRC

TCON

THAR

URBN

Shares of Urban Outfitters, Inc. (NASDAQ: URBN) dipped during Wednesday’s session after the company reported third-quarter financial results.

Why Urban Outfitters Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

Edesa Biotech Inc

Walmart, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) announced on Monday an updated brand identity that includes subtle changes to its wordmark and spark logo, as well as <a href="https://www.benzinga.com/trading-ideas/25/01/42755273/exclusive-top-20-most-searched-tickers-on-benzinga-pro-in-december-2024-where-do-tesla-nvidia-quantum-computing-stock-rank">its color palette.</a>
The Details: The mega-retailer worked with creative agency Jones Knowles Ritchie to create its updated<a href="https://corporate.walmart.com/news/2025/01/13/walmart-introduces-updated-look-and-feel-a-testament-to-heritage-and-innovation"> brand identity</a> which the company says aims to "build credibility and connection, become known for its convenient digital-first services and be seen as a more modern, culturally dynamic brand."
Read Next: <a href="https://www.benzinga.com/25/01/42919029/supreme-court-hears-tiktok-oral-arguments">Supreme Court Hears TikTok Arguments With App&#8217;s Ban Ahead: &#8216;Essentially, The Platform Shuts Down&#8217;&nbsp;</a>
Walmart's iconic spark logo remains similar, yet slightly thicker and bolder.&nbsp;
"We wanted to put more depth and impact to it, so it exudes a bit more Walmart energy and serves as a beacon for the brand," William White, senior vice president and chief marketing officer of Walmart U.S., <a href="https://www.fastcompany.com/91057001/impossibles-massive-meatier-new-brand-promises-that-plants-can-bleed-red">told</a> Fast Company.&nbsp;
The new wordmark was inspired by founder Sam Walton's classic trucker hat with "Walmart" written in the typeface Antique Olive.&nbsp;
"Walmart aims to be an inspirational, digital retailer that provides all the products, brands and services our customers need and want. This update, rooted in the legacy of our founder, Sam Walton, demonstrates our evolving capabilities and longstanding commitment to serve our customers of today and tomorrow," said White.&nbsp;
Walmart says starting this month the new brand identity will officially roll out on Walmart.com, the Walmart app, marketing campaign assets and its corporate site.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/legal/25/01/42953761/santa-ana-winds-return-as-la-wildfire-damage-estimates-rise-to-at-least-250-billion-fire-officials-investigate-downed-power-lines">Santa Ana Winds Return As LA Wildfire Damage Estimates Rise To At Least $250 Billion, Fire Officials Investigate Downed Power Lines</a></li>
</ul>
Photo: Courtesy Walmart

Large Cap

General

Walmart Refreshes Image With New Brand Identity

Many Americans likely tuned into the first round of the 2024 NFL Playoffs over the weekend with teams fighting for a chance to advance to <a href="https://www.benzinga.com/topic/nfl">Super Bowl LIX.</a>
One game featured a rather unique sideline sighting that could help a self-help author far beyond belief.
What Happened: The Philadelphia Eagles defeated the Green Bay Packers 22-10 Sunday night in a<a href="https://www.benzinga.com/general/sports/25/01/42829221/how-to-watch-nfl-playoffs-super-bowl-lix-betting-odds-will-history-be-made-by-chiefs-or-lions"> game shown on FOX</a>, a unit of FOX Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOX#NASDAQ">FOX</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOXA#NASDAQ">FOXA</a>).
The win gets the Eagles closer to Super Bowl LIX and wide receiver A.J. Brown closer to another chance at winning the Lombardi Trophy.
In six seasons with the Tennessee Titans and Eagles, Brown has nine playoff appearances, including three in 2022 where the Eagles lost Super Bowl LVII to the Kansas City Chiefs 35 to 38. In that Super Bowl, Brown had six catches for 96 yards and a touchdown.
Brown didn't have the normal strong stats Sunday against the Packers, posting only one catch for 10 yards on three targets, but he quickly became one of the most talked about players during and after the game.
Fox cameras caught Brown reading a book on the sideline, which later turned out to be self-help book, "Inner Excellence," from performance coach Jim Murphy.
"Discover the life guide that has developed world champions, empowered athletes to become world #1 and most importantly, transformed their hearts and minds. This step-by-step training manual from one of the world's top mental skills coaches will teach you how to train your mind like the very best," a description of the book on Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) <a href="https://www.amazon.com/INNER-EXCELLENCE-Extraordinary-Performance-Possible/dp/1734654805?tag=googhydr-20&amp;source=dsa&amp;hvcampaign=books&amp;gclid=Cj0KCQiAkJO8BhCGARIsAMkswyjiuw6_zmBe-nFjIGhq2Rw4DXj1jVfgmdsmw1vMVJlqeJ_PiOnHsNAaAjElEALw_wcB">reads</a>.
The book, with the subtitle of "Train Your Mind for Extraordinary Performance and the Best Possible Life," hit number one on Amazon Monday as the top-selling book, as <a href="https://www.sportico.com/personalities/athletes/2025/aj-brown-book-reading-inner-excellence-sales-philadelphia-1234823669/">reported </a>by Sportico.
Before Monday, the book was ranked #552,709, the report said.
Seeing Brown read the book on the sideline led to huge interest in the book on Amazon. Murphy, who has coached athletes and leaders, including Olympic athletes, may want to send a thank you note Brown's way.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The book AJ Brown is reading is called &#39;Inner Excellence&#39; &#x1f4da; &#x1f4fa; FOX <a href="https://t.co/9o1RGD9hLn">pic.twitter.com/9o1RGD9hLn</a>
&mdash; FOX Sports: NFL (@NFLonFOX) <a href="https://twitter.com/NFLonFOX/status/1878601077542490471?ref_src=twsrc%5Etfw">January 13, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Brown was asked about the viral moment after Sunday's victory.
"My teammates call it ‘the recipe,'" Brown said. "It's got a lot of points in there, it's a lot of mental game, a lot of mental parts about it, and you know for me this game is mental."
Brown said a teammate recommended the book to him last year and he now carries it on the sideline and looks back at points from the book during games.
The Eagles wide receiver <a href="https://x.com/ZachGelb/status/1878611786213269543">told </a>reporters he wasn't reading the book due to the outcome of the game or his individual performance.
"No, I was not frustrated at all. I figured that's what y'all probably thought. I wasn't frustrated. Why do y'all think I'm frustrated? I read the book. I like to read."
Brown was open about his mental health in 2021, sharing that he previously spoke to a therapist and telling people that it&#8217;s okay to seek help and talk to someone.
Read Also: <a href="https://www.benzinga.com/general/sports/25/01/42884959/detroit-lions-take-a-bite-out-of-sportsbooks-analyst-advises-patience-after-flutter-cuts-guidance">Detroit Lions Take Bite Out Of Sportsbooks: Analyst Advises Patience After Flutter Cuts Guidance</a>
What's Next: Brown and his teammates may want to read the book and keep looking at how they can perform best in the 2024 NFL Playoffs.
The Eagles will play the winner of Monday's Los Angeles Rams and Minnesota Vikings contest in the second round of the playoffs. That game is set for 7 p.m. ET on NBC, a unit of Comcast Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCSA#NASDAQ">CMCSA</a>).
Brown and his sideline reading material will likely be a subject discussed during the game and cameras may be set on the wide receiver to catch him reading once again.
The Eagles have odds of +450 to win Super Bowl LIX at sportsbook DraftKings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>), ranking third behind the Detroit Lions (+285) and Kansas City Chiefs (+350).
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/sports/24/12/42521231/travis-hunter-wins-heisman-will-he-be-1-pick-in-2025-nfl-draft-what-betting-odds-history-show">Travis Hunter Wins Heisman, Will He Be #1 Pick In 2025 NFL Draft? What Betting Odds, History Show</a></li>
</ul>
Photo: Fabio Alcini via Shutterstock

Sports Betting

Psychology

Sports

AMZN

CMCSA

DKNG

FOXA

NFL Star Helps Self-Help Book Hit #1 On Amazon: 'My Teammates Call It The Recipe'

Axon Enterprise (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXON#NASDAQ">AXON</a>) has outperformed the market over the past 5 years by 38.66% on an annualized basis producing an average annual return of 50.52%. Currently, Axon Enterprise has a market capitalization of $43.36 billion. 
Buying $1000 In AXON: If an investor had bought $1000 of AXON stock 5 years ago, it would be worth $7,560.22 today based on a price of $568.68 for AXON at the time of writing.
<h3>Axon Enterprise's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736811907_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AXON

Here's How Much $1000 Invested In Axon Enterprise 5 Years Ago Would Be Worth Today

Amazon has long been a lifeline for businesses wanting to reach millions of customers. But for some, that lifeline turns into an anchor dragging them down. Mark Cuban, billionaire investor and entrepreneur, recently shared strong views on Amazon's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) impact on businesses, particularly those relying heavily on the platform.
Cuban described Amazon&#8217;s seller fees as &#8220;insane and unsustainable&#8221; and cautioned that businesses that rely too much on Amazon run serious risks. &#8220;When I look at investing in companies,&#8221; Cuban <a href="https://x.com/mcuban/status/1875326196612739526">tweeted</a>, &#8220;if you have any level of dependency on Amazon, it's a negative.&#8221; He's not alone in his concerns – criticism about Amazon's practices is mounting.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">When I look at investing in companies, if you have any level of dependency on Amazon, its a negative. I would love to have people post what percent of sales in fees from Amazon and Walmart they are experiencing The numbers I have seen are INSANE AND UNSUSTAINABLE. That&#39;s… <a href="https://t.co/i0psZcK2Le">https://t.co/i0psZcK2Le</a>
&mdash; Mark Cuban (@mcuban) <a href="https://twitter.com/mcuban/status/1875326196612739526?ref_src=twsrc%5Etfw">January 3, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Don't Miss:
<ul>
<li>It&#8217;s no wonder Jeff Bezos holds over $70 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a></li>
<li>With 100+ historic trademarks including some of the high grossing characters in history, like Cinderella, Snow White and Peter Pan, <a href="https://www.benzinga.com/money/elf-labs-1">this company is transforming the $2 trillion entertainment market with patented AR, VR, and AI tech. — For a short window, investors are able to claim $2/share ($980 min).</a></li>
</ul>
<h2 class="wp-block-heading">The Counterfeit Crisis</h2>
<a href="https://www.benzinga.com/insights/news/24/12/42702567/understanding-amazon-coms-position-in-broadline-retail-industry-compared-to-competitors">Amazon's marketplace</a>, which allows third-party sellers to sell their goods, accounts for over half of its retail sales. While this has brought in record revenues, it's also opened the floodgates to counterfeits.&nbsp;
Businesses like Crye Precision, a military gear manufacturer, are hit hard. CNBC recently reported that counterfeit versions of its patented MultiCam camouflage – found on products like tactical vests and backpacks – <a href="https://www.benzinga.com/markets/equities/24/09/41053761/american-eagle-sues-amazon-for-trademark-infringement-report">regularly pop up on Amazon</a>. These fakes don't just cost Crye money; they're also dangerous. For example, some of the fake camouflage doesn't work with night vision.
Crye isn't the only brand experiencing a slump. Apple, Birkenstock, Ikea and Nike have all stopped selling directly on Amazon, citing counterfeit issues and what they describe as a &#8220;wild west&#8221; environment.&nbsp;
In 2020, Amazon established the Counterfeit Crimes Unit (CCU) to combat the issue. Through raids and the seizure of millions of counterfeit goods, the unit collaborates with law enforcement and brands to disrupt counterfeiting networks. Despite these efforts, the sheer scale of the platform makes it nearly impossible to eliminate the problem.
See Also: ‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a>
<h2 class="wp-block-heading">Cuban's Proposal to Protect American Businesses</h2>
In response to Scott Adams <a href="https://x.com/ScottAdamsSays/status/1875153196542480582">sharing</a> that &#8220;100% of the Dilbert calendars on Amazon are fake,&#8221; Mark Cuban has <a href="https://x.com/mcuban/status/1875234461928825002">proposed</a> a series of major changes to help protect American companies from knockoffs, particularly those coming from China. He proposes asking importers to pay $25,000 bonds to increase financial accountability to cover possible intellectual property infractions.&nbsp;
Cuban also suggests that before products are marketed, they should be registered on a government website for evaluation, allowing brands to confirm their authenticity. To cover these processes, importers must pay fees, which Cuban believes would discourage low-value knockoff goods from entering the market.&nbsp;
He also wants to shift the responsibility for proving compliance onto the importers instead of leaving American businesses to bear that burden. Automating these systems could make them more efficient and Cuban suggests hefty fines for retailers caught selling counterfeit products.&nbsp;
Trending: <a href="https://www.benzinga.com/money/qnetic-2">This 12,000 RPM Spinning Battery With Over $100 Million In LOIs Could Be The Missing Link For Green Energy — Here&#8217;s Why Early Investors Are Flocking To Invest Before Funding Closes</a>
He claimed that these adjustments are &#8220;how you get China to pay. And how you at least start to protect American companies, from being knocked off.&#8221;
<h2 class="wp-block-heading">Amazon's &#8220;Insane&#8221; Fees</h2>
On top of the fake product problem, Cuban also pointed out how much Amazon charges its sellers. While Amazon gives sellers access to many customers, businesses feel squeezed by the high fees that eat into their margins. Cuban has called for transparency, urging businesses to share how much of their revenue goes to fees paid to Amazon and Walmart. &#8220;The numbers I have seen are INSANE AND UNSUSTAINABLE,&#8221; he tweeted.
<h2 class="wp-block-heading">A Bigger Problem in E-Commerce</h2>
The counterfeit issue isn't unique to Amazon. Platforms like <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39708215/amazon-vs-temu-shein-tiktok-shop-whos-winning-the-us-e-commerce-battle">Temu, Shein and TikTok Shop</a> have also drawn criticism for selling cheap knockoffs, often shipped directly from China. CNBC cites a 2023 study that found that about one in three adults in the U.S. have knowingly bought a &#8220;dupe,&#8221; or a cheaper version of a popular product. While some see this as saving money, it's bad news for companies trying to sell real products.
Read Next:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
</ul>

Mark Cuban Says He Avoids Investing In Companies Dependent On Amazon, Calling Their Seller Fees 'Insane And Unsustainable'

FTAI Aviation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTAI#NASDAQ">FTAI</a>) has outperformed the market over the past 5 years by 46.45% on an annualized basis producing an average annual return of 58.31%. Currently, FTAI Aviation has a market capitalization of $16.87 billion. 
Buying $100 In FTAI: If an investor had bought $100 of FTAI stock 5 years ago, it would be worth $1,009.02 today based on a price of $164.50 for FTAI at the time of writing.
<h3>FTAI Aviation's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736811008_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FTAI

$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today

Mortgage rates last week reached their highest levels since July 2024 with the average 30-year fixed mortgage rate staying above 7%, according to Bankrate. Experts see rates remaining elevated through the first <a href="https://www.benzinga.com/news/25/01/42934513/job-growth-fed-jitters-and-rising-mortgage-rates-this-week-in-economics">six months of 2025</a>.&nbsp;
The Details: Mortgage rates have climbed higher following recent economic data which has dampened Wall Street's expectations for the Federal Reserve to cut rates in the near future and caused 10-year Treasury yields to surge.&nbsp;
Read Next: <a href="https://www.benzinga.com/25/01/42919029/supreme-court-hears-tiktok-oral-arguments">Supreme Court Hears TikTok Arguments With App&#8217;s Ban Ahead: &#8216;Essentially, The Platform Shuts Down&#8217;&nbsp;</a>
Mortgage applications are down as high interest rates continue to deter potential homebuyers. According to the most<a href="https://www.mba.org/news-and-research/newsroom/news/2025/01/08/mortgage-applications-decrease-in-latest-mba-weekly-survey"> recent data</a> from the Mortgage Bankers Association's Weekly Mortgage Applications Survey, mortgage applications decreased 3.7% last week.&nbsp;
"Applications decreased last week as rising mortgage rates continued to discourage buyers from entering the market and put a damper on purchase activity. The 30-year fixed rate increased for the fourth consecutive week, reaching 6.99 percent — the highest rate since July 2024," said Joel Kan, MBA's vice president and deputy chief economist.
What To Expect: Zillow expects <a href="https://www.zillow.com/research/2025-housing-predictions-34620/">more home sales</a> and modest home value growth of 2.6% in 2025 as the market "slowly becomes unstuck." Zillow forecasts 4.3 million existing home sales in 2025, up slightly from 4.1 million in 2023 and a projected 4 million in 2024. 
But, most experts see mortgage rates <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/42764583/mortgage-rates-soar-to-697-applications-crash-jobless-claims-fall-thursdays-econ-data">remaining close</a> to the 7% level in the near term as markets digest uncertainty about the incoming Trump administration's policies which some think could reignite inflation.&nbsp;
"As for whether or not we&#8217;ll see recalibration over the next few weeks, that depends on what the president-elect says and what he does when he actually takes office,&#8221; said Jacob Channel, senior economist at LendingTree as <a href="https://www.cnet.com/personal-finance/mortgage-predictions-for-week-of-jan-13-19-everything-to-know-about-rates/">reported by</a> CNET.&nbsp;
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/legal/25/01/42953761/santa-ana-winds-return-as-la-wildfire-damage-estimates-rise-to-at-least-250-billion-fire-officials-investigate-downed-power-lines">Santa Ana Winds Return As LA Wildfire Damage Estimates Rise To At Least $250 Billion, Fire Officials Investigate Downed Power Lines</a></li>
</ul>
Photo: Shutterstock

Bonds

Federal Reserve

Real Estate

Housing Demand Falls As Average 30-Year Mortgage Rate Above 7%

Monolithic Power Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MPWR#NASDAQ">MPWR</a>) has outperformed the market over the past 5 years by 14.6% on an annualized basis producing an average annual return of 26.46%. Currently, Monolithic Power Systems has a market capitalization of $28.65 billion. 
Buying $100 In MPWR: If an investor had bought $100 of MPWR stock 5 years ago, it would be worth $325.69 today based on a price of $587.35 for MPWR at the time of writing.
<h3>Monolithic Power Systems's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736809208_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MPWR

If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today

The wildfires in California continue to see devastation with 24 people dead and more than 12,000 structures destroyed. The sports and entertainment sectors are among those tackling the impact and making changes to the schedule as <a href="https://www.benzinga.com/news/legal/25/01/42953761/santa-ana-winds-return-as-la-wildfire-damage-estimates-rise-to-at-least-250-billion-fire-officials-investigate-downed-power-lines">relief efforts continue.</a>
Entertainment World Reacts: The wildfires saw several TV shows delay production last week and multiple Los Angeles <a href="https://www.benzinga.com/general/entertainment/25/01/42888380/los-angeles-fires-shut-down-production-of-tv-shows-fallout-abbott-elementary-hacks-film-premieres-canceled-critics-choice-awards-delayed">movie premieres canceled.</a>
Musician Beyoncé announced a $2.5 million donation to Eaton Fire victims through her BeyGOOD nonprofit, as reported by <a href="https://deadline.com/2025/01/los-angeles-wildfires-celebrity-donations-volunteer-1236253904/">Deadline</a>. The relief fund will help families who lost their homes and go to churches and community centers to help in the relief efforts.
Paris Hilton, who lost her Malibu beach house in the fires, launched an emergency fund through her 11:11 Media nonprofit for the relief efforts. The fund started with Hilton's initial contribution of $100,000 and she is matching up to $100,000 in additional donations made.
Actresses Jennifer Garner, Halle Berry, Sharon Stone and actor Sean Penn were also named in the report as celebrities helping to mobilize donations to those in need after the fires.
Jennifer Lopez canceled several media appearances in the upcoming days to focus on helping the wildfire relief efforts.
Actress Jamie Lee Curtis and her family donated $1 million to the relief efforts.
Following last week's announced award show impacts from the wildfires, the Academy Awards also made a notable change this week. The movie award show extended the voting deadline through Friday and will wait to announce nominations on Jan. 23, versus an original plan of announcing nominations on Jan. 17.
The Academy Awards are set to be shown on ABC on March 2. The show will honor frontline workers "who have aided with the fire," as <a href="https://www.nytimes.com/2025/01/13/movies/oscar-nominations-fires.html">reported </a>by the New York Times.
The Grammy Awards, set for Feb. 2 on CBS, will also honor first responders.
Read Also: <a href="https://www.benzinga.com/general/space/25/01/42939786/despite-elon-musks-feud-with-gavin-newsom-tesla-rolls-out-support-for-california-amid-wildfires-with-cybertrucks-starlink-and-megapack-chargers">Despite Elon Musk&#8217;s Feud With Gavin Newsom, Tesla Rolls Out Support For California Amid Wildfires With Cybertrucks, Starlink And Megapack Chargers</a>
Sports World Reacts: One of the biggest impacts of the California wildfires on the sporting world will be on full display Monday night with the NFL Playoff game between the Los Angeles Rams and Minnesota Vikings moved from Los Angeles to Arizona.
"The decision was made in consultation with public officials, the participating clubs and the NFLPA," the NFL <a href="https://www.nfl.com/news/vikings-rams-wild-card-game-on-monday-moved-to-arizona-due-to-los-angeles-area-fires">said</a>.
The Rams will lose its home-field advantage and now take on the Vikings in a neutral location. The Vikings who were early favorites for the game saw their odds improve from -1 to -2.5 at sportsbooks like DraftKings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>) after the venue change was announced.
ESPN and ABC, units of Walt Disney Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>), will air Monday's game at 8 p.m. ET. The wildfires will likely be a big storyline discussed before and during the game and the Rams could see some extra fans rooting for them given the situation in California.
The NFL is <a href="https://www.nfl.com/news/nfl-family-contributes-5-million-to-los-angeles-wildfire-relief-efforts">donating </a>over $5 million to the wildfire relief efforts, gathering donations from clubs and ownership groups.
"The NFL family is committed to working with the Los Angeles Chargers and Los Angeles Rams to support their local communities in their time of need," NFL Commissioner Roger Goodell said.
Twelve Los Angeles professional sports teams, which are spread across MLB, NBA, NFL, NHL, MLS and NWSL are donating a total of $8 million to the wildfire relief efforts, Yahoo Sports <a href="https://sports.yahoo.com/all-12-los-angeles-area-professional-sports-teams-donate-8-million-to-fire-relief-efforts-210643707.html">reported</a>.
The money will be spread out to several organizations including the Los Angeles Fire Department Foundation, World Central Kitchen and the American Red Cross, according to the report. Sports apparel company Fanatics also partnered with the Los Angeles area teams to distribute $3 million in team merchandise to families that evacuated their homes.
Fanatics also launched "LA Strong" shirts to benefit the American Red Cross and the Los Angeles Fire Department Foundation.
The wildfires have led to the <a href="https://www.benzinga.com/general/sports/25/01/42889402/nhl-game-canceled-after-los-angeles-fires-nfl-monitoring-situation-ahead-of-monday-playoff-game">postponement of games</a> across the NHL and NBA in Los Angeles along with Monday night's NFL game move.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/25/01/42962518/meghan-markle-netflix-delay-launch-of-cooking-reality-show-after-california-fires-focus-on-the-needs-of-those-impacted">Meghan Markle, Netflix Delay Launch Of Cooking Reality Show After California Fires: &#8216;Focus on The Needs Of Those Impacted&#8217;</a></li>
</ul>
Photo: Shutterstock

Entertainment

Media

Beyoncé Pledges $2.5 Million To Help California Wildfire Relief Efforts; NFL Donates $5 Million, Moves Monday's Playoff Game To Arizona

Management

RMBL

RumbleOn Promotes Cameron Tkach To Executive Vice President And COO; Becca Polak Named As Vice Chairman And Lead Independent Director

RumbleOn Says Michael Kennedy Is No Longer CEO Or Member Of Board Of Directors; Names Chairman Michael Quartieri As CEO

AutoZone (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZO#NYSE">AZO</a>) has outperformed the market over the past 5 years by 11.06% on an annualized basis producing an average annual return of 22.92%. Currently, AutoZone has a market capitalization of $54.37 billion. 
Buying $100 In AZO: If an investor had bought $100 of AZO stock 5 years ago, it would be worth $283.65 today based on a price of $3239.62 for AZO at the time of writing.
<h3>AutoZone's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736808309_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In AutoZone 5 Years Ago Would Be Worth Today

Celsius Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELH#NASDAQ">CELH</a>) has outperformed the market over the past 10 years by 57.01% on an annualized basis producing an average annual return of 68.16%. Currently, Celsius Holdings has a market capitalization of $6.36 billion. 
Buying $1000 In CELH: If an investor had bought $1000 of CELH stock 10 years ago, it would be worth $180,826.48 today based on a price of $27.28 for CELH at the time of writing.
<h3>Celsius Holdings's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736806508_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CELH

Here's How Much You Would Have Made Owning Celsius Holdings Stock In The Last 10 Years

"My first legal joint burned like hell. It was hot, the material was dried out, and it canoed," recalls Kyle Loucks, founder and CEO of <a href="https://www.benzinga.com/topic/rollpros">RollPros</a>, as he describes the experience that led to his work in the cannabis pre-roll space. For Loucks, that moment wasn't just a personal disappointment, it brought a major realization. What was supposed to be a magical milestone, celebrating legalization and quality craftsmanship, turned into an encounter with a product that fell far short of expectations. Instead of moving on, Loucks decided to do something about it.
<h3 class="wp-block-heading">The Problem With Pre-Rolls: A Connoisseur&#8217;s Perspective</h3>
Loucks&#8217; first pre-roll was meant to be a celebration, a symbol of how far the industry had come. Instead, it exposed a persistent problem in the market. "I saw a problem," he says. "This is not my level of joint." For someone who had spent more than 20 years perfecting the art of rolling by hand, encountering such a poorly made product sparked an idea. Retreating to his garage, Loucks began working on a solution that could deliver consistent, high-quality joints at scale.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="683" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13152502/RollPros-Blackbird_1-1024x683.jpg" alt="RollPros Blackbird" class="wp-image-731271" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13152502/RollPros-Blackbird_1-1024x683.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13152502/RollPros-Blackbird_1-300x200.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13152502/RollPros-Blackbird_1-768x512.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13152502/RollPros-Blackbird_1-1536x1025.jpg 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13152502/RollPros-Blackbird_1.jpg 1619w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
At the core of his solution is TruRoll technology, a proprietary system that flips the traditional cone-filling process on its side—literally. "We feed horizontally, so you can fill fresh, sticky weed with a big grind size. Then we roll it and tighten it as we go. It's just a better way to make a joint," Loucks explains.
The horizontal feeding approach addresses a common challenge with cones: their narrow aperture, which often leads to uneven packing and airflow issues. By rethinking the mechanics of rolling, Loucks developed a system that preserves the integrity of fresh flower while ensuring a consistent burn. His invention appeals not just to craft growers but also to larger operators looking for efficiency without sacrificing quality.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How To Roll The PERFECT JOINT: One Machine Produces 900 Pre-Rolls An Hour–They Are Better Than Cones" width="500" height="281" src="https://www.youtube.com/embed/-JhsMzXkjDw?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
<h3 class="wp-block-heading">Craft Meets Automation</h3>
RollPros&#8217; flagship product, the Blackbird Rolling System, is designed for cannabis enthusiasts who value both precision and consistency. It combines Loucks' hands-on experience with advanced automation to replicate the quality of hand-rolled joints on an industrial scale. "We've done over 80 million joints now and have about 160 machines out in the wild," Loucks shares, highlighting the growing demand for his technology.
The Blackbird's design focuses on preserving what makes a joint special. "I selfishly designed it for myself," Loucks says, emphasizing his personal standards as a cannabis connoisseur who values fresh flower and optimal burn quality. "I like a large grind size to keep all those flavonoids and terpenes on the plant," he adds. To complement this, RollPros sources high-quality paper from one of the oldest paper mills in France, ensuring an even, smooth burn.
Beyond quality, the Blackbird is also about flexibility. Operators can customize nearly every aspect of the rolling process, from density and draw resistance to the type of filter or paper used. "You can do big fatties, little pinners, ceramic tips, glass tips, wood tips—it's all customizable," Loucks explains. The machine's adaptability allows brands to tailor their products to meet the specific preferences of their customers, creating a unique identity in a competitive market.
<h3 class="wp-block-heading">Meeting The Needs Of Craft Growers And Beyond</h3>
For Loucks, the design of the Blackbird Rolling System was always rooted in serving the craft cannabis community, those who value quality and freshness over mass production. "It's really tailored for the craft grower," he explains. Inspired by the dedication of phenohunters and small-scale cultivators in places like the Emerald Triangle, Loucks wanted to create a tool that could seamlessly integrate into these operations while maintaining the standards of hand-rolled joints.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="683" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13152511/Kyle-Loucks_Founder-and-CEO-RollPros-1024x683.jpg" alt="Kyle Loucks" class="wp-image-731274" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13152511/Kyle-Loucks_Founder-and-CEO-RollPros-1024x683.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13152511/Kyle-Loucks_Founder-and-CEO-RollPros-300x200.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13152511/Kyle-Loucks_Founder-and-CEO-RollPros-768x512.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13152511/Kyle-Loucks_Founder-and-CEO-RollPros-1536x1025.jpg 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13152511/Kyle-Loucks_Founder-and-CEO-RollPros.jpg 1619w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
The Blackbird's compact size makes it an ideal fit for such setups. Measuring approximately four feet by two feet and standing about four feet tall, it's no larger than two college refrigerators placed side by side. "It's on casters, so you can roll it from room to room," Loucks adds.
However, the machine's utility doesn't stop at the craft level. The Blackbird has also gained traction among larger players in the cannabis industry, including multi-state operators (MSOs) looking for efficient and scalable solutions. "We've got all the way up to the big MSOs using our equipment," Loucks shares. "It's great to see the big guys starting to look at us and being like, ‘This is how you make a quality consumer experience.'"
<h3 class="wp-block-heading">The Investment And ROI Equation</h3>
Of course, innovation comes at a price. The Blackbird Rolling System is an investment, with a starting cost of approximately $250,000. For some operators, that might seem like a steep entry point, but Loucks points out that the machine's scalability and potential for high-volume output can make it a cost-effective choice in the long run. With the ability to produce roughly 900 joints per hour, the system can quickly pay for itself in the right hands.
Loucks recounts the story of a particularly resourceful customer who purchased a Blackbird and turned it into a mobile rolling service. "He had it in a trailer and would roll it onto farms to offer rolling as a service. Then he'd pack it back up and head to the next place," Loucks explains. This entrepreneurial approach not only provided immediate value to local growers but also allowed the customer to recoup his investment faster than expected.
For operators who may not have the upfront capital, RollPros offers leasing options to make the technology more accessible. This flexibility ensures that craft growers and boutique operations can still benefit from the Blackbird's capabilities without being priced out of the market.
<h3 class="wp-block-heading">Beyond Rolling: The Future Of Cannabis Innovation</h3>
While the Blackbird Rolling System has carved out a niche for itself in the cannabis pre-roll market, Loucks is already looking ahead to the next set of challenges facing the industry. "I think packaging is next," he says, pointing to sustainability as a critical area for improvement. The current options for pre-roll packaging often rely on single-use plastics or other environmentally unfriendly materials, a problem Loucks believes can be addressed with the same innovative mindset that brought TruRoll technology to life. "I want to find some more sustainable options for packaging, but I've got to do it with the same level of innovation that I did with the Blackbird."
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="683" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13152507/Blackbird-Rolled-Joints_1-1024x683.jpg" alt="" class="wp-image-731273" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13152507/Blackbird-Rolled-Joints_1-1024x683.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13152507/Blackbird-Rolled-Joints_1-300x200.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13152507/Blackbird-Rolled-Joints_1-768x512.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13152507/Blackbird-Rolled-Joints_1-1536x1025.jpg 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13152507/Blackbird-Rolled-Joints_1.jpg 1619w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Loucks' approach to problem-solving is rooted in collaboration. "I love to brainstorm," he shares. "Hit me up on LinkedIn, let's do a Zoom, I'll get the whiteboard out—tell me your problem." For Loucks, innovation doesn't happen in isolation. By inviting growers, operators and other industry professionals to share their pain points, he aims to create solutions that are not just technically sound but deeply aligned with the needs of the cannabis community.
<h3 class="wp-block-heading">Crafting A Ritual, One Joint At A Time</h3>
Despite the technological sophistication of the Blackbird, Loucks is quick to acknowledge the irreplaceable value of the human touch in cannabis culture. For many enthusiasts, rolling a joint is as much about the ritual as it is about the final product. Loucks, a self-described "ritual guy," understands this intimately. "Rolling a joint is like making espresso," he says. "It's about the smell, the feel, the whole experience."
This perspective is woven into the very fabric of RollPros. While the Blackbird enables consistent, high-quality production at scale, it doesn't seek to replace the craft of rolling by hand. Instead, it provides a tool for those who want to take their craft to the next level, blending tradition with innovation. "The people that are really successful with our machine are joint rollers and joint smokers," Loucks explains. "They know what a good joint feels like, and they can dial in the machine to hit all those same parameters."
<h3 class="wp-block-heading">A Growing Legacy</h3>
With more than 80 million joints produced and a growing roster of customers ranging from boutique craft growers to large-scale MSOs, RollPros is becoming a cornerstone of the cannabis pre-roll industry. Loucks credits much of this success to his ability to remain connected to the community he serves. Whether through brainstorming sessions, hands-on product development or simply sharing his passion for well-rolled joints, Loucks keeps his focus on the people who make the cannabis industry what it is.
As he reflects on his journey, Loucks remains energized by the challenges that lie ahead. "There are big problems all across the industry," he says. "And I'm here to help solve them."
Images courtesy of RollPros.

Cannabis

Exclusives

Interview

'This Is How You Make Quality Joints' - How One Machine Produces 900 Pre-Rolls An Hour And Why They're Better Than Cones

B2Gold Expects Total Gold Production To Be 970K - 1.075M Ounces; Reports Total Gold Production Of 186,001 Ounces In Q4

Guidance

Alamos Gold Says 3-Year Operating Guidance Outlines 24% Production Growth By 2027; Starts Construction On Lynn Lake

4 analysts have expressed a variety of opinions on Houlihan Lokey (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLI#NYSE">HLI</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $180.5, a high estimate of $200.00, and a low estimate of $170.00. Witnessing a positive shift, the current average has risen by 7.6% from the previous average price target of $167.75.
<img src="https://www.benzinga.com/files/images/story/2025/1736805657_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Houlihan Lokey. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Aidan Hall</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$170.00</td>
<td>$172.00</td>
</tr>
<tr>
<td>Aidan Hall</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$172.00</td>
<td>$171.00</td>
</tr>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Underweight</td>
<td>$180.00</td>
<td>$157.00</td>
</tr>
<tr>
<td>Manan Gosalia</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Underweight</td>
<td>$200.00</td>
<td>$171.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Houlihan Lokey. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Houlihan Lokey compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Capture valuable insights into Houlihan Lokey's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/HLI/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Houlihan Lokey analyst ratings.</a>
<h2>Unveiling the Story Behind Houlihan Lokey</h2>
Houlihan Lokey Inc is an investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments worldwide with offices in the United States, Europe, and the Asia-Pacific region. The company operates in three segments. In the Corporate Finance business segment, it provides M&amp;A and capital markets advisory services. Through the Financial Restructuring business segment, the company advises on some of the complex restructurings around the world. Financial and Valuation Advisory Services business segment provides valuation and financial opinion, and financial and strategic consulting practices in the United States.
<h3>Unraveling the Financial Story of Houlihan Lokey</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3 months period, Houlihan Lokey showcased positive performance, achieving a revenue growth rate of 23.12% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Financials sector.
Net Margin: Houlihan Lokey's net margin is impressive, surpassing industry averages. With a net margin of 16.27%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Houlihan Lokey's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 4.94%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Houlihan Lokey's ROA excels beyond industry benchmarks, reaching 3.04%. This signifies efficient management of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.22.
<h2>How Are Analyst Ratings Determined?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Forecasting The Future: 4 Analyst Projections For Houlihan Lokey

During the last three months, 6 analysts shared their evaluations of ITT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ITT#NYSE">ITT</a>), revealing diverse outlooks from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for ITT, revealing an average target of $173.17, a high estimate of $183.00, and a low estimate of $163.00. This current average has increased by 3.69% from the previous average price target of $167.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1736805647_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The perception of ITT by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Vladimir Bystricky</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$181.00</td>
<td>$183.00</td>
</tr>
<tr>
<td>Nathan Jones</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$180.00</td>
<td>$171.00</td>
</tr>
<tr>
<td>Vladimir Bystricky</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$183.00</td>
<td>$176.00</td>
</tr>
<tr>
<td>Joseph Giordano</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Buy</td>
<td>$165.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Michael Halloran</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$163.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Nathan Jones</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$167.00</td>
<td>$157.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to ITT. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of ITT compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for ITT's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into ITT's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ITT/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on ITT analyst ratings.</a>
<h2>Unveiling the Story Behind ITT</h2>
ITT Inc is a diversified manufacturer of engineered critical components and customized technology solutions predominantly for the transportation, industrial and energy markets. The company's products include, brake pads, shock absorbers, pumps, valves, connectors, switches and others. Its operating segments are; Motion Technologies (MT), Industrial Process (IP), and Connect &amp; Control Technologies (CCT). The majority of the revenue is generated from the Motion Technologies segment which is a manufacturer of brake pads, shims, shock absorbers, energy absorption components and sealing technologies. Geographically, the company generates majority of the revenue from North America, and also has its presence in South America, Europe, Asia, Middle East and Africa.
<h3>Unraveling the Financial Story of ITT</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Over the 3 months period, ITT showcased positive performance, achieving a revenue growth rate of 7.68% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Industrials sector.
Net Margin: ITT's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 18.2% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): ITT's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 6.05%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): ITT's ROA excels beyond industry benchmarks, reaching 3.44%. This signifies efficient management of assets and strong financial health.
Debt Management: ITT's debt-to-equity ratio is below the industry average. With a ratio of 0.34, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Analyst Ratings: Simplified</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Assessing ITT: Insights From 6 Financial Analysts

Across the recent three months, 14 analysts have shared their insights on Coterra Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTRA#NYSE">CTRA</a>), expressing a variety of opinions spanning from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">9</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">3</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $33.79, a high estimate of $40.00, and a low estimate of $29.00. This upward trend is evident, with the current average reflecting a 7.03% increase from the previous average price target of $31.57.
<img src="https://www.benzinga.com/files/images/story/2025/1736805639_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
A comprehensive examination of how financial experts perceive Coterra Energy is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Neal Dingmann</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$37.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Mark Lear</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$33.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Nitin Kumar</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Outperform</td>
<td>$40.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Scott Gruber</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$32.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Roger Read</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$35.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Josh Silverstein</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$35.00</td>
<td>$31.00</td>
</tr>
<tr>
<td>Devin McDermott</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$29.00</td>
<td>$27.00</td>
</tr>
<tr>
<td>Neal Dingmann</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$33.00</td>
<td>$31.00</td>
</tr>
<tr>
<td>Mark Lear</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$35.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Betty Jiang</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$33.00</td>
<td>$31.00</td>
</tr>
<tr>
<td>Biju Perincheril</td>
<td>Susquehanna</td>
<td>Raises</td>
<td>Positive</td>
<td>$33.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Mark Lear</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$32.00</td>
<td>$31.00</td>
</tr>
<tr>
<td>Mike Scialla</td>
<td>Stephens &amp; Co.</td>
<td>Raises</td>
<td>Overweight</td>
<td>$29.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Nitin Kumar</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Outperform</td>
<td>$37.00</td>
<td>$36.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Coterra Energy. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Coterra Energy compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Coterra Energy's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Coterra Energy's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CTRA/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Coterra Energy analyst ratings.</a>
<h2>About Coterra Energy</h2>
Coterra Energy Inc is an independent oil and gas company engaged in the development, exploration, and production of oil, natural gas, and NGLs. The company's operations are primarily concentrated in three core operating areas; the Permian Basin in west Texas and southeast New Mexico, the Marcellus Shale in northeast Pennsylvania, and the Anadarko Basin in the Mid-Continent region in Oklahoma.
<h3>Breaking Down Coterra Energy's Financial Performance</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Coterra Energy's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 0.22%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Energy sector.
Net Margin: Coterra Energy's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 18.47%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Coterra Energy's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 1.93%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Coterra Energy's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 1.23%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Coterra Energy's debt-to-equity ratio is below the industry average at 0.18, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Analyst Ratings: What Are They?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CTRA

Forecasting The Future: 14 Analyst Projections For Coterra Energy

Throughout the last three months, 5 analysts have evaluated APi Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APG#NYSE">APG</a>), offering a diverse set of opinions from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $43.4, a high estimate of $45.00, and a low estimate of $40.00. Surpassing the previous average price target of $42.80, the current average has increased by 1.4%.
<img src="https://www.benzinga.com/files/images/story/2025/1736805628_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The standing of APi Gr among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Andrew Kaplowitz</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$43.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Andrew Kaplowitz</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$45.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>Andrew Wittmann</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$40.00</td>
<td>$39.00</td>
</tr>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$44.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Ashish Sabadra</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$45.00</td>
<td>$45.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to APi Gr. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of APi Gr compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of APi Gr's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/APG/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on APi Gr analyst ratings.</a>
<h2>All You Need to Know About APi Gr</h2>
APi Group Corp operates in two segments: Safety Services segment includes providing safety services in North America, Asia Pacific, and Europe, focusing on end-to-end integrated occupancy systems (fire protection solutions, Heating, Ventilation, and Air Conditioning and entry systems), including design, installation, inspection, and service of these integrated systems. These services are provided in commercial, education, healthcare, high tech, industrial, and special-hazard settings. Specialty Services segment includes providing a variety of infrastructure services and specialized industrial plant services, which include maintenance and repair of critical infrastructure such as underground electric, gas, water, sewer, and telecommunications infrastructure.
<h3>APi Gr's Financial Performance</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Revenue Growth: APi Gr's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of 2.35%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 3.4%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): APi Gr's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 2.14%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 0.77%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: With a high debt-to-equity ratio of 1.06, APi Gr faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Deep Dive Into APi Gr Stock: Analyst Perspectives (5 Ratings)

Across the recent three months, 11 analysts have shared their insights on Bicycle Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCYC#NASDAQ">BCYC</a>), expressing a variety of opinions spanning from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">7</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $35.18, along with a high estimate of $55.00 and a low estimate of $17.00. Experiencing a 12.27% decline, the current average is now lower than the previous average price target of $40.10. 
<img src="https://www.benzinga.com/files/images/story/2025/1736805620_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The analysis of recent analyst actions sheds light on the perception of Bicycle Therapeutics by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Swayampakula Ramakanth</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$33.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Ami Fadia</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$32.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Reni Benjamin</td>
<td>JMP Securities</td>
<td>Lowers</td>
<td>Market Outperform</td>
<td>$26.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Swayampakula Ramakanth</td>
<td>HC Wainwright &amp; Co.</td>
<td>Lowers</td>
<td>Buy</td>
<td>$33.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Kalpit Patel</td>
<td>B. Riley Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$17.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Sudan Loganathan</td>
<td>Stephens &amp; Co.</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$25.00</td>
<td>-</td>
</tr>
<tr>
<td>Gregory Renza</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$35.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Swayampakula Ramakanth</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$55.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Ami Fadia</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$38.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Swayampakula Ramakanth</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$55.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Ami Fadia</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$38.00</td>
<td>$38.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Bicycle Therapeutics. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Bicycle Therapeutics compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Bicycle Therapeutics's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
For valuable insights into Bicycle Therapeutics's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/BCYC/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Bicycle Therapeutics analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>About Bicycle Therapeutics</h2>
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.
<h3>Understanding the Numbers: Bicycle Therapeutics's Finances</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Challenges: Bicycle Therapeutics's revenue growth over 3 months faced difficulties. As of 30 September, 2024, the company experienced a decline of approximately -50.0%. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: Bicycle Therapeutics's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -1898.43%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of -5.96%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Bicycle Therapeutics's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -4.95%, the company may face hurdles in achieving optimal financial returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.01.
<h2>How Are Analyst Ratings Determined?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BCYC

Forecasting The Future: 11 Analyst Projections For Bicycle Therapeutics

Edesa Biotech (EDSA) has released an update. Edesa Biotech's novel drug, paridiprubart, has been selected by the U.S. Biomedical Advanced Research ...

Edesa Biotech's ARDS Drug Chosen for US Trial

Vernon Bernardino, an analyst from H.C. Wainwright, reiterated the Buy rating on Edesa Biotech (EDSA – Research Report). The associated price targe...

Promising Outlook for Edesa Biotech's Paridiprubart: A Buy Rating Justified by BARDA-Backed ARDS Study and Broad Therapeutic Potential

Edesa Biotech GAAP EPS of -$0.52 beats by $0.06

Edesa Biotech (EDSA) has released an update. Edesa Biotech, a clinical-stage biopharmaceutical company, has announced its third-quarter financials ...

Edesa Biotech Showcases Steady Q3 2024 Financials

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Edesa Biotech (NASDAQ:<a href="https://investorplace.com/stock-quotes/edsa-stock-quote/">EDSA</a>) just reported results for the third quarter of 2024.<ul><li>Edesa Biotech reported earnings per share of -52 cents. This was above the analyst estimate for EPS of -58 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/edsa-stock-earnings-edesa-biotech-for-q3-of-2024/">EDSA Stock Earnings: Edesa Biotech Beats EPS for Q3 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

EDSA Stock Earnings: Edesa Biotech Beats EPS for Q3 2024

Buy Rating Affirmed for Edesa Biotech Amidst Strong Government Support and Promising Drug Pipeline

Edesa Biotech ( ($EDSA) ) has issued an update. Edesa Biotech, Inc. has partnered with H.C. Wainwright & Co., LLC to periodically sell its common s...

Edesa Biotech Partners with Wainwright for Share Sales

Edesa Biotech (EDSA) has released an update. Edesa Biotech, a clinical-stage biopharmaceutical company, is set to participate in multiple internati...

Edesa Biotech to Present at Global Conferences

Edesa Biotech GAAP EPS of -$1.93 beats by $0.22

Edesa Biotech (EDSA) has released an update. Edesa Biotech reported a significant decrease in operating expenses for fiscal year 2024, with a pivot...

Edesa Biotech Enhances Financial Position and Strategy

Biotech

Events

Press Releases

Edesa Biotech to Participate in Barclays Global Healthcare Conference

Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Conference

Edesa Biotech to Participate in Upcoming Investor Conferences

Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference

Earnings

Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results

BARDA Selects Edesa Biotech's Drug for U.S. Funded Platform Trial in General ARDS

Comments

Edesa Biotech

Edesa Biotech (EDSA) Forecast

Edesa Biotech (NASDAQ:EDSA) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga